Solid Lipid Nanoparticles of Mycophenolate Mofetil: An Attempt to Control the Release of an Immunosuppressant.
Asma IqbalMuhammad ZamanMuhammad Wahab AmjadSharjeel AdnanMaria Abdul Ghafoor RajaSyed Farhan Haider RizviMian Waqar MustafaUmer FarooqGhulam AbbasShahid ShahPublished in: International journal of nanomedicine (2020)
The findings show potential applications of the nanoparticles and the method for the development of SLNPs in controlled release of MMF for better therapeutic outcomes. Conclusively, the prepared SLNPs were well designed in nanosized ranges and justifying the once daily controlled release formulation dose of MMF to enhance patient compliance.